Advertisement
Advertisement

DERM

DERM logo

Journey Medical Corporation Common Stock

8.37
USD
Sponsored
+0.02
+0.18%
Feb 06, 15:57 UTC -5
Closed
exchange

After-Market

8.37

0.00
0.00%

DERM Earnings Reports

Positive Surprise Ratio

DERM beat 5 of 16 last estimates.

31%

Next Report

Date of Next Report
Mar 19, 2026
Estimate for Q4 25 (Revenue/ EPS)
$19.24M
/
-$0.05
Implied change from Q3 25 (Revenue/ EPS)
+9.13%
/
-44.44%
Implied change from Q4 24 (Revenue/ EPS)
+41.26%
/
-66.67%

Journey Medical Corporation Common Stock earnings per share and revenue

On Nov 12, 2025, DERM reported earnings of -0.09 USD per share (EPS) for Q3 25, missing the estimate of -0.04 USD, resulting in a -85.57% surprise. Revenue reached 17.63 million, compared to an expected 19.23 million, with a -8.32% difference. The market reacted with a -15.31% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.05 USD, with revenue projected to reach 19.24 million USD, implying an decrease of -44.44% EPS, and increase of 9.13% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, Journey Medical Corporation Common Stock reported EPS of -$0.09, missing estimates by -85.57%, and revenue of $17.63M, -8.32% below expectations.
The stock price moved down -15.31%, changed from $9.08 before the earnings release to $7.69 the day after.
The next earning report is scheduled for Mar 19, 2026.
Based on 6 analysts, Journey Medical Corporation Common Stock is expected to report EPS of -$0.05 and revenue of $19.24M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement